Page last updated: 2024-08-25

1-triacontanol and Chronic Disease

1-triacontanol has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ghosal, C; Joseph, A; Kamath, SU; Kandwal, M; Kumar, S; Naduvil Narayanan, S; Nayak, BS; Rao, KR; Sahoo, P; Snehunsu, A; Srinivasan, KK; Yadav, PK	1

Other Studies

1 other study(ies) available for 1-triacontanol and Chronic Disease

Article	Year
1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats. Journal of ethnopharmacology, 2015, Aug-22, Volume: 172 Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Epilepsy, Generalized; Fatty Alcohols; Frontal Lobe; Glutathione; Hippocampus; Malondialdehyde; Marsileaceae; Oxidative Stress; Pentylenetetrazole; Rats; Valproic Acid	2015

Article

Year

1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats.

Journal of ethnopharmacology, 2015, Aug-22, Volume: 172

Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Epilepsy, Generalized; Fatty Alcohols; Frontal Lobe; Glutathione; Hippocampus; Malondialdehyde; Marsileaceae; Oxidative Stress; Pentylenetetrazole; Rats; Valproic Acid

2015